As expected, we observed that TP53 gene mutation was associated with a faster clinical progression in CLL (P = 0.0259), as shown by a shorter TTFT in Kaplan–Meier curves (Fig. 2f). This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.